Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Quiz

Phase 3 Data Reveal RSV Vaccine's Efficacy and Safety

Maria Asimopoulos

The RSVPreF3 OA vaccine is being tested in an ongoing, international, phase 3 trial with participants aged 60 years and older. Researchers recently reported efficacy and safety data.

Advertisement

Advertisement

Advertisement